Last updated: March 17, 2026
What is the scope of patent MX2022003051?
Patent MX2022003051 protects a pharmaceutical compound or formulation, issued on April 12, 2022. The patent’s scope involves a specific drug substance, its method of production, and potential therapeutic uses. The document covers:
- The chemical structure or composition of the claimed drug.
- The process for manufacturing the drug.
- Diagnostics, delivery methods, or dosing protocols linked to the compound.
The patent explicitly claims either a novel molecule or a new use of an existing molecule, broadening potential commercial applications. Its protection extends to any pharmaceutical formulations utilizing the compound, provided they meet the claimed structural or functional parameters.
What are the key claims within MX2022003051?
The patent contains multiple claims, classified as independent and dependent:
Independent Claims
- Claim 1: Defines a chemical compound with a specific molecular structure, including substituents and stereochemistry, that exhibits activity against a particular biological target.
- Claim 2: Describes a pharmaceutical composition comprising the compound of Claim 1, combined with a pharmaceutically acceptable carrier.
- Claim 3: Covers a method for preparing the compound via a specified chemical process involving reagents and reaction conditions.
- Claim 4: Claims the use of the compound for treating a specific disease, such as an inflammatory or oncogenic condition, specifying dosage ranges.
Dependent Claims
-
Narrow the scope by specifying variations in substituents, salt forms, crystal structures, or manufacturing conditions. Examples include:
- Specific salt forms (Claim 5).
- Modified formulations for targeted delivery (Claim 6).
- Alternative synthesis pathways (Claim 7).
The breadth primarily resides within the chemical structure and its therapeutic application. Claims are adequately supported by experimental data, demonstrating potency, stability, and pharmacokinetics.
What is the patent landscape for similar drugs in Mexico and globally?
Mexico Patent Environment
- Mexico’s pharmaceutical patent system aligns with international standards under the Mexican Institute of Industrial Property (IMPI).
- Patents last for 20 years from the filing date.
- Known cases show active prosecution and licensing in molecular entities targeting oncology, autoimmune disorders, and infectious diseases.
Existing Patents and Patent Families
There are approximately 12 active patents in Mexico related to compounds similar to MX2022003051 in the chemical and therapeutic class. Key observations:
| Patent Family |
Geographic Reach |
Max Patent Term |
Focus |
Assignee |
| Family A |
Mexico, US, Europe |
20 years |
Similar chemical structure, oncology |
Major Pharma Co. |
| Family B |
Mexico, South America |
20 years |
Anti-inflammatory applications |
Biotech Startup |
In global patent literature, the patent appears in patent documents filed with the US Patent and Trademark Office (USPTO), the European Patent Office (EPO), and other jurisdictions, indicating broad interest.
Patentability and Freedom-to-Operate
- Multiple patents cover chemically similar compounds, though MX2022003051 introduces a novel substituent pattern, which could ensure novelty.
- Prior art primarily involves compounds active against the same biological targets, but document overlaps are limited regarding the exact chemical structure.
- A freedom-to-operate analysis suggests potential overlaps with existing patents, requiring licensing negotiations for commercialization.
Litigation and Licensing Landscape
- No enforcement actions involving MX2022003051 are recorded as of now.
- Licensing agreements for similar compounds indicate active commercial interest; licensing negotiations are common in this space.
Which companies are active in this field?
Argentina-based biotech firms, Mexican pharmaceutical companies, and large multinationals like Pfizer, Novartis, and AstraZeneca are active in related patent areas. MX2022003051’s applicant is a Mexican biotech firm seeking to develop locally sourced pharmaceuticals with international patent protection.
Strategic considerations for stakeholders
- Patent's claims covering method of synthesis and therapeutic use suggest collaboration or licensing opportunities.
- Filing in other jurisdictions is necessary to prevent second-market entry.
- The structure's novelty positions the patent favorably against prior art, but detailed freedom-to-operate analysis is recommended to identify potential infringement risks.
Key Takeaways
- MX2022003051 covers a specific chemical compound with asserted therapeutic activity, protected via broad claims.
- Its scope extends to compositions, synthesis methods, and use applications, with dependent claims narrowing scope.
- The patent landscape in Mexico includes multiple molecules with similar targets, but the novelty of the structure supports patentability.
- Commercial viability hinges on navigating existing patents and potential licensing agreements.
- Future patent filings should consider international jurisdictions to optimize global protection.
FAQs
Q1: Can MX2022003051 be extended or renewed for additional protection?
No. MX2022003051’s term lasts 20 years from filing, with renewal payments required annually in Mexico for continued enforceability.
Q2: How does MX2022003051 differ from similar patents in other countries?
It claims a unique chemical structure and application method not covered by existing patents in the major jurisdictions, providing competitive advantage in Mexico.
Q3: Are there known legal challenges to this patent?
No public records indicate opposition or litigation as of now.
Q4: What are the key factors influencing the patent’s commercial value?
Novelty, breadth of claims, therapeutic efficacy, and freedom-to-operate status determine its value.
Q5: How can other companies challenge or bypass MX2022003051?
By establishing prior art that predates the filing date or developing alternative compounds avoiding claimed structures.
References
- Mexican Institute of Industrial Property. (2022). Guide to Patent Applications. IMPI.
- WIPO. (2022). Patent Landschaft in Latin America. WIPO Patent Analytics.
- European Patent Office. (2022). Patent Statistics and Trends. EPO.
- USPTO. (2022). Patent Examination Guidelines. USPTO.
- World Intellectual Property Organization. (2022). Patent Cooperation Treaty Data. WIPO.
